FAS Wealth Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $203K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $327K | Buy |
|
|||||
|
2022
Q1 | $317K | Buy |
|
|||||
|
2021
Q4 | $318K | Sell |
|
|||||
|
2021
Q3 | $946K | Sell |
|
|||||
|
2021
Q2 | $1M | Buy |
|
|||||
|
2021
Q1 | $883K | Sell |
|
|||||
|
2020
Q4 | $932K | Buy |
|
|||||
|
2020
Q3 | $924K | Buy |
|
|||||
|
2020
Q2 | $967K | Sell |
|
|||||
|
2020
Q1 | $899K | Buy |
|
|||||
|
2019
Q4 | $847K | Buy |
|
|||||
|
2019
Q3 | $763K | Buy |
|
|||||
|
2019
Q2 | $687K | Buy |
|
|||||
|
2019
Q1 | $697K | Buy |
|
|||||
|
2018
Q4 | $631K | Buy |
|
|||||
|
2018
Q3 | $658K | Buy |
|
|||||
|
2018
Q2 | $654K | Buy |
|
|||||
|
2018
Q1 | $631K | Buy |
|
|||||
|
2017
Q4 | $567K | Sell |
|
|||||
|
2017
Q3 | $689K | Buy |
|
|||||
|
2017
Q2 | $662K | Buy |
|
|||||
|
2017
Q1 | $640K | Sell |
|
|||||
|
2016
Q4 | $595K | Buy |
|
|||||
|
2016
Q3 | $544K | Buy |
|
|||||
|
2016
Q2 | $489K | Buy |
|
|||||
|
2016
Q1 | $447K | Buy |
|
|||||
|
2015
Q4 | $334K | Buy |
|
|||||
|
2015
Q3 | $300K | Buy |
|
|||||
|
2015
Q2 | $200K | Sell |
|
|||||
|
2015
Q1 | $232K | Sell |
|
|||||
|
2014
Q4 | $232K | Buy |
|
|||||
|
2014
Q3 | $249K | Sell |
|
|||||
|
2014
Q2 | $303K | Sell |
|
|||||
|
2014
Q1 | $336K | Buy |
|
|||||
|
2013
Q4 | $335K | Buy |
|